Sonoma Biotherapeutics Stock

sonomabio.comBioTechFounded: 2019Funding to Date: $335.1MM

Sonoma Biotherapeutics is a biotech company focused on the development of adoptive Treg cell therapies for autoimmune and inflammatory diseases.

Register for Details

For more details on financing and valuation for Sonoma Biotherapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Sonoma Biotherapeutics.

Register Today

Other companies like Sonoma Biotherapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$3.1B
Sector
 
 
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$1.77B